Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction

Background Dyslipidemia is common in heart failure with preserved ejection fraction. Sacubitril/valsartan improves glycemic control and augments natriuretic peptide signaling, providing mechanisms by which sacubitril/valsartan may affect serum lipids. However, empiric data on these effects are lacki...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Senthil Selvaraj, Brian L. Claggett, Milton Packer, Faiez Zannad, Inder S. Anand, Burkert Pieske, Ziqiang Zhao, Victor C. Shi, Martin P. Lefkowitz, John J. V. McMurray, Scott D. Solomon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-09-01
coleção:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	heart failure with preserved ejection fraction lipids metabolism sacubitril/valsartan
Acesso em linha:	https://www.ahajournals.org/doi/10.1161/JAHA.121.022069
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!